MedTrace Logo

COVID 19 and Psychological Health: a Cross Sectional Study to Evaluate Anxiety and Depression in Covid-19 Patients

NCT04689464 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2021-06-08

No results posted yet for this study

Summary

The covid-19 pandemic started to spread worldwide since December 2019. It promoted to an exaggerated psychological stress and anxiety in humans due to the intolerable symptoms higher than usual death of many infected patients. This study examines the corona related anxiety and if there is need for drug intervention to treat this anxiety.

To answer these questions, a survey made to the hospitalized patients including sex, age, educational level, Marital state, and a standardized questionnaires (GAD-7 and PHQ-9) which has been validated and shown to possess good psychometric qualities in studies of participants from multiple populations.

Conditions

Sponsors & Collaborators

  • University of Basrah

    collaborator OTHER

  • Ministry of Health, Iraq

    collaborator NETWORK

  • Alhasan Mujtaba Al-Mudhaffer

    lead OTHER

Principal Investigators

  • Zainab N Abdul-nabi, M.Sc. · University of Basrah

  • Hiba Dawood, M.Sc. · University of Basrah

  • Qussay N Almaliki, Ph.D. · AlFayhaa teaching hospital

  • Nadheera F Neamah · University of Basrah

  • Dania Zydoon · Al-Sader teaching hospital

  • Zainab Mahdi · Al-Mawani general hospital

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2021-05-28
Completion
2021-06-01

Countries

  • Iraq

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04689464 on ClinicalTrials.gov